Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin Rural Emergency Hospitals — Transformative Change or Limited Impact? [PODCAST] - (Posted On Wednesday, March 22, 2023) Recent Developments to the 340B Drug Pricing Program [PODCAST] - (Posted On Thursday, December 15, 2022) New Data Available Under the Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, November 17, 2022) Genesis Healthcare and the 340B Program Patient Definition [PODCAST] - (Posted On Tuesday, August 09, 2022) Supreme Court Issues Decision Favorable to Hospitals on 340 B Payment Reduction: What to Do Next - (Posted On Tuesday, June 21, 2022) Medicare Reimbursement for Community Hospital Residency Programs [PODCAST] - (Posted On Monday, January 31, 2022) 2022 OPPS Final Rule Overview: CMS Finalizes Policies on 340B, Hospital Price Transparency, and Inpatient-Only List - (Posted On Monday, November 08, 2021) An Update on the CMS Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, October 21, 2021) CMS Proposes to Increase Penalties for Hospital Price Transparency Noncompliance - (Posted On Thursday, July 22, 2021) 340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case - (Posted On Thursday, July 08, 2021) Pagination Page 1 Next page Next › Current Legal Analysis Are Summer Camp Liability Waivers Valid if a Camper is Injured? by: Lawrence J. Buckfire Your Website Travels & So Does the Law: What the Ninth Circuit’s Shopify Ruling Means for E-Commerce Jurisdiction in California by: Alkida Kacani , América Garza California Bill Would Ban Ultra-Processed Foods in Schools by: Food and Drug Law at Keller and Heckman Nebraska’s New Sick Leave Law Explained by: Catherine A. Cano , Michaelle L. Baumert FDA Lessens Hurdles for Color Additive Changes in Drugs by: Food and Drug Law at Keller and Heckman The Economic Loss Doctrine: A Valuable Shield for Lenders by: Lance P. Martin , Thomas C. Wolff Presidential Proclamation Announces New Entry Restrictions on Nationals of 19 Countries by: Nataliya Rymer , Claudia Isabel Oviedo Call for Evidence for Impact Assessment of the European Biotech Act Will Close June 11, 2025 by: Lynn L. Bergeson , Carla N. Hutton Big Beautiful Bill Means Big Cuts for Clean Energy Manufacturers by: James V. Aidala , L. Claire Hansen SCOTUS Declines to Decide Fate of Classes with Uninjured Members: 8-1 Decision in LabCorp Leaves Unresolved Whether Rule 23 Allows Certification for a Class Containing Members Who Lack Standing by: Tammana Malik Breaking—Supreme Court Unanimously Lowers Bar for “Reverse Discrimination” Claims: Ames v. Ohio Department of Youth Services Redefines Title VII Litigation by: Allison N. Powers , Theresa A. Topping Beltway Buzz, June 6, 2025 by: James J. Plunkett Trump Security Plan Equals New Travel Ban by: Lynn O'Brien House Bill 3809 Adds Obligations to Battery Energy Storage Lessees in Texas by: Eric Blumrosen , David G. Cabrales Guide to Buying Buildings from the Federal Government: Where to Start and What to Know by: Pamela V. Rothenberg , Patrice Z. Howard, Ph.D. Upcoming Events Jun 9 2025 The First 100 Days and Beyond Under the New Administration | Session 4: FDA-Regulated Products, Consumer Goods and Advertising Practices Jun 10 2025 Energy Emergency: Agency Implementation of Executive Order 14156 in Permitting and Review Jun 10 2025 Update on EU Sustainability Regulations Jun 10 2025 ACC NYC General Counsel Toolkit - AI in the Workplace: Legal Implications for Employers Print
